Order Demonstrates Continued Success in Transportation Security Markets

WILMINGTON, Mass.–Implant Sciences Corporation (OTCBB:IMSC – News), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced an order totaling approximately $1.2 million for its Quantum Sniffer™ QS-H150 Portable Explosives Detectors to be delivered to governmental customers of the Company’s distributor in China. The QS-H150’s will be deployed for use in transportation security applications in multiple locations throughout China.

Glenn D. Bolduc, Implant Sciences’ President and CEO, commented, “This is an important win for Implant Sciences as it represents follow-on business from the Company’s successes in China last year, and validates our reputation for on-time delivery of high-performance, high-quality solutions.”

Mr. Bolduc continued, “This is a significant competitive success as well. We believe that Implant Sciences is the sole awardee following a competitive evaluation, and that the order strengthens the Company’s position as the supplier of choice for portable explosives trace detectors, as China’s transportation security infrastructure continues its rapid growth.”

The QS-H150 provides high performance and reliability combined with a very low cost of ownership. Annual maintenance costs are minimal and consist primarily of normal care and cleaning using common supplies. Calibration is autonomous, continuous, and requires no consumables. Since there are no radioactive materials used in the QS-H150, there are no associated certifications, licenses, inspections, or end-of-life disposal issues. As such, customers have an outstanding, cost effective product available to them in support of efforts to improve their overall security profile and meet mission critical objectives.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for the Security, Safety and Defense (SS&D) industries. The Company has developed proprietary technologies used in its commercial portable and bench-top explosive trace detection systems which ship to a growing number of locations domestically and internationally. For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain “forward-looking statements,” as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management’s current expectations and are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that: if the NYSE Alternext US delists our common stock, it may be extremely difficult to raise capital; if third party credit is unavailable, our working capital could be restricted and we may not be able to borrow capital; and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management’s current expectations and assumptions which could differ materially from the forward-looking statements.